• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全转录组测序的参芪复方保护血管内皮细胞免受高糖损伤的关键 circRNAs、lncRNAs 和 mRNAs。

Key circRNAs, lncRNAs, and mRNAs of ShenQi Compound in Protecting Vascular Endothelial Cells From High Glucose Identified by Whole Transcriptome Sequencing.

机构信息

Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan, China.

Hospital of Chengdu University of Traditional Chinese Medicine, TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Sichuan, Chengdu, China.

出版信息

J Cardiovasc Pharmacol. 2023 Apr 1;81(4):300-316. doi: 10.1097/FJC.0000000000001403.

DOI:10.1097/FJC.0000000000001403
PMID:36701487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10079301/
Abstract

Vascular endothelial cells, which make up the inner wall of blood arteries, are susceptible to damage from oxidative stress and apoptosis caused by hyperglycemia. According to certain reports, noncoding RNAs are involved in controlling oxidative stress and apoptosis. ShenQi Compound (SQC), a traditional herbal remedy, has been successfully treating diabetic vascular disease in China for more than 20 years. Although it is well established that SQC protects the vascular endothelium, the molecular mechanism remains unknown. Goto-Kakizaki rats, spontaneous type II diabetes rats, that consistently consume a high-fat diet were chosen as model animals. Six groups (control group, model group, metformin group, and 7.2 g/kg/d SQC group, 14.4 g/kg/d SQC group, and 28.8 g/kg/d SQC group) were included in this work, 15 rats each group. The approach of administration was gavage, and the same volume (5.0 mL/kg/d) was given in each group, once a day, 12 weeks. The thoracic aortas were removed after the rats were sacrificed. Oxidative reduction profile in thoracic aorta, histopathological observation of thoracic aorta, endothelial cell apoptosis in thoracic aorta, whole transcriptome sequencing, bioinformatic analyses, and qRT-PCR were conducted. As a result, SQC prevented the oxidative stress and apoptosis induced by a high glucose concentration. Under hyperglycemia condition, noncoding RNAs, including 1 downregulated novel circRNA (circRNA.3121), 3 downregulated lncRNAs (Skil.cSep08, Shawso.aSep08-unspliced, and MSTRG.164.2), and 1 upregulated mRNA (Pcdh17), were clearly reverse regulated by SQC. SQC plays a role in protecting vascular endothelial cells from high glucose mainly by mediating ncRNA to inhibit cell apoptosis and oxidative stress.

摘要

血管内皮细胞构成了动脉血管的内壁,易受到高血糖引起的氧化应激和细胞凋亡的损伤。有报道称,非编码 RNA 参与调控氧化应激和细胞凋亡。参芪复方(SQC)作为一种传统的草药制剂,在中国成功治疗糖尿病血管疾病已有 20 多年的历史。虽然 SQC 能保护血管内皮细胞已得到广泛证实,但其中的分子机制尚不清楚。本研究选用自发性 2 型糖尿病大鼠(Goto-Kakizaki 大鼠)作为模型动物,该大鼠持续摄入高脂肪饮食。实验共分为 6 组(对照组、模型组、二甲双胍组和 SQC 低、中、高剂量组),每组 15 只。灌胃给药,各组给予相同体积(5.0 mL/kg/d),每天 1 次,连续 12 周。处死大鼠后取其胸主动脉。检测胸主动脉氧化还原状态、胸主动脉组织病理学观察、胸主动脉内皮细胞凋亡、全转录组测序、生物信息学分析和 qRT-PCR。结果显示,SQC 可预防高糖诱导的氧化应激和细胞凋亡。在高糖环境下,SQC 可明显逆转 1 个下调的新型环状 RNA(circRNA.3121)、3 个下调的长链非编码 RNA(Skil.cSep08、Shawso.aSep08-unspliced 和 MSTRG.164.2)和 1 个上调的 mRNA(Pcdh17)的表达。SQC 主要通过调节 ncRNA 抑制细胞凋亡和氧化应激来保护血管内皮细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/8a01f09fda57/jcvp-81-300-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/f93c859f380e/jcvp-81-300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/58d77fc3d458/jcvp-81-300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/803d34b5de5a/jcvp-81-300-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/5b23556a0f9f/jcvp-81-300-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/7fa76cd2dc03/jcvp-81-300-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/29a07220ab55/jcvp-81-300-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/8a01f09fda57/jcvp-81-300-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/f93c859f380e/jcvp-81-300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/58d77fc3d458/jcvp-81-300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/803d34b5de5a/jcvp-81-300-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/5b23556a0f9f/jcvp-81-300-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/7fa76cd2dc03/jcvp-81-300-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/29a07220ab55/jcvp-81-300-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e979/10079301/8a01f09fda57/jcvp-81-300-g007.jpg

相似文献

1
Key circRNAs, lncRNAs, and mRNAs of ShenQi Compound in Protecting Vascular Endothelial Cells From High Glucose Identified by Whole Transcriptome Sequencing.基于全转录组测序的参芪复方保护血管内皮细胞免受高糖损伤的关键 circRNAs、lncRNAs 和 mRNAs。
J Cardiovasc Pharmacol. 2023 Apr 1;81(4):300-316. doi: 10.1097/FJC.0000000000001403.
2
[Effects of shenqi compound on the mRNA expression of AT1R in the aorta of GK rats].[参芪复方对GK大鼠主动脉AT1R mRNA表达的影响]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Mar;33(3):351-5.
3
Exploration of SQC Formula Effect on Type 2 Diabetes Mellitus by Whole Transcriptome Profile in Rats.基于全转录组谱的 SQC 配方对 2 型糖尿病大鼠的作用探索。
Endocr Metab Immune Disord Drug Targets. 2021;21(7):1261-1269. doi: 10.2174/1871530321666210225125141.
4
Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification.参芪复方抑制糖尿病血管钙化的作用及机制。
Mol Med. 2023 Dec 13;29(1):168. doi: 10.1186/s10020-023-00767-7.
5
Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.转录组分析确定了一个新的 3-LncRNA 调控网络,该网络可减轻转甲状腺素蛋白在糖尿病视网膜病变中葡萄糖诱导的 hRECs 功能障碍。
BMC Med Genomics. 2019 Oct 15;12(1):134. doi: 10.1186/s12920-019-0596-2.
6
Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.参芪复方通过调节肠道微生物群和代谢物改善 2 型糖尿病。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Apr 1;1194:123189. doi: 10.1016/j.jchromb.2022.123189. Epub 2022 Feb 24.
7
Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model.参芪复方对自发性糖尿病大鼠模型的作用及机制探究
Endocr Metab Immune Disord Drug Targets. 2019;19(5):622-631. doi: 10.2174/1871530319666190225113859.
8
[Effect of Shenqi compound on PTEN/PI3K signal transduction in GK rats with diabetes mellitus macroangiopathy].[参芪复方对糖尿病大血管病变GK大鼠PTEN/PI3K信号转导的影响]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Jun;30(6):640-4.
9
Characterization of lncRNA and mRNA profiles in rats with diabetic macroangiopathy.糖尿病大血管病变大鼠 lncRNA 和 mRNA 谱的特征分析。
PLoS One. 2020 Dec 30;15(12):e0243987. doi: 10.1371/journal.pone.0243987. eCollection 2020.
10
The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass.参芪复方在 2 型糖尿病中的保护作用:对胰腺β细胞功能和质量的综合研究。
Biomed Pharmacother. 2023 Oct;166:115287. doi: 10.1016/j.biopha.2023.115287. Epub 2023 Aug 10.

引用本文的文献

1
Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification.参芪复方抑制糖尿病血管钙化的作用及机制。
Mol Med. 2023 Dec 13;29(1):168. doi: 10.1186/s10020-023-00767-7.